Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib
収録刊行物
-
- Clin Cancer Res
-
Clin Cancer Res 12 839-844, 2006